Advances in Treatment
NIAID is making major advances in the science of treating the flu (influenza).
Scientists recently studied the frequency with which the H3N2 influenza virus developed drug-resistant mutations in 50 Japanese children taking oseltamivir.
NIAID grantees are exploring ways some futuristic technologies might lead to better flu drugs.
Popular antiviral treatment for type A flu doesn't work against a type B strain. Now NIAID-supported researchers have figured out why.